Targeted therapeutic strategies for anti-neoplastic activity in ovarian carcinomas - Towards individualized cancer therapy
- Prosjektnummer
- 911809
- Ansvarlig person
- Line Bjørge
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskningsprosjekt
- Helsekategori
- Cancer
- Forskningsaktivitet
- 2. Aetiology, 5. Treatment Developement
The Norwegian preeclampsia family cohort study: a new resource for investigating genetic aspects and heritability of preeclampsia and related phenotypes.
BMC Pregnancy Childbirth 2015;15(1):319. Epub 2015 des 1
PMID: 26625711
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol 2016 Jan;17(1):78-89. Epub 2015 nov 16
PMID: 26590673
Metabolic profiles of placenta in preeclampsia using HR-MAS MRS metabolomics.
Placenta 2015 Dec;36(12):1455-62. Epub 2015 nov 5
PMID: 26582504
Refined phenotyping identifies links between preeclampsia and related diseases in a Norwegian preeclampsia family cohort.
J Hypertens 2015 Nov;33(11):2294-302.
PMID: 26259119
Shared genetics underlying epidemiological association between endometriosis and ovarian cancer.
Hum Mol Genet 2015 Oct 15;24(20):5955-64. Epub 2015 jul 30
PMID: 26231222
Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk.
Cancer Epidemiol Biomarkers Prev 2015 Oct;24(10):1574-84. Epub 2015 jul 24
PMID: 26209509
Genome-wide significant risk associations for mucinous ovarian carcinoma.
Nat Genet 2015 Aug;47(8):888-97. Epub 2015 jun 15
PMID: 26075790
Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
J Nucl Med 2015 Aug;56(8):1191-8. Epub 2015 jun 4
PMID: 26045311
Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.
Hum Mol Genet 2015 Jul 1;24(13):3595-607. Epub 2015 mar 24
PMID: 25804953
Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas.
Clin Radiol 2015 May;70(5):487-94. Epub 2015 jan 30
PMID: 25639620
Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas.
Int J Gynecol Cancer 2015 Mar;25(3):459-66.
PMID: 25628109
Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients.
Cancer Immunol Immunother 2015 Mar;64(3):337-47. Epub 2014 nov 22
PMID: 25416072
Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas.
Br J Cancer 2014 Jan 7;110(1):107-14. Epub 2013 okt 31
PMID: 24178757
Landscape of genomic alterations in cervical carcinomas.
Nature 2014 Feb 20;506(7488):371-5. Epub 2013 des 25
PMID: 24390348
First in-mouse development and application of a surgically relevant xenograft model of ovarian carcinoma.
PLoS One 2014;9(3):e89527. Epub 2014 mar 4
PMID: 24594904
Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation.
Acta Obstet Gynecol Scand 2014 Jul;93(7):647-53. Epub 2014 mai 23
PMID: 24766569
[Anticoagulation for venous thrombosis in pregnancy].
Tidsskr Nor Laegeforen 2014 May 13;134(9):926. Epub 2014 mai 13
PMID: 24828717
Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence.
Eur Radiol 2013 Oct;23(10):2916-25. Epub 2013 jun 4
PMID: 23732687
Menstrual cycle and respiratory symptoms in a general Nordic-Baltic population.
Am J Respir Crit Care Med 2013 Feb 15;187(4):366-73. Epub 2012 nov 29
PMID: 23204251
Validity of the diagnosis of pre-eclampsia in the Medical Birth Registry of Norway.
Acta Obstet Gynecol Scand 2013 Aug;92(8):943-50. Epub 2013 mai 29
PMID: 23621424
Preeclampsia: Specific genetic risk factors and shared predisposition with cardiovascular disease
- Disputert:
- mars 2015
- Hovedveileder:
- Line Bjørge
Implementation of Medical Abortion in Norway1998-2013
- Disputert:
- april 2015
- Hovedveileder:
- Line Bjørge
Toll-like receptors and inflammation in pregnancy
- Disputert:
- oktober 2015
- Hovedveileder:
- Ann-Charlotte Iversen
Ovarian cancer: A clinical challenge that needs basic answers
- Disputert:
- mai 2014
- Hovedveileder:
- Line Bjørge
- Emmet Mc Cormack Medveileder
- Line Bjørge Prosjektleder
- Øystein Helland Ph.d.-kandidat
- Helga Birgitte Salvesen Prosjektdeltaker
- Stian Knappskog Prosjektdeltaker
- Katharina Bischof Ph.d.-kandidat
- Bjørn Tore Gjertsen Medveileder
- Kjetil Tasken Prosjektdeltaker
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest